All patients (n = 839) | Non-survivors (n = 222) | Survivors (n = 617) | P-value | |
---|---|---|---|---|
Age, median (range) | 73 (18–103) | 79.5 (22–103) | 70 (18–100) | < 0.0001 |
Sex, male | 411 (49%) | 120 (54.05%) | 291 (47.16%) | 0.078 |
COPD | 230 (27.4%) | 50 (23.36%) | 180 (30.05%) | 0.062 |
Diabetes | 173 (20.6%) | 64 (29.91%) | 109 (18.20%) | 0.0003 |
Drug abuse | 13 (1.5%) | 0 (0%) | 13 (2.17%) | 0.03 |
Heart failure | 94 (11.2%) | 43 (20.09%) | 51 (8.51%) | < 0.0001 |
Hypertension | 272 (32.4%) | 76 (35.51%) | 196 (32.72%) | 0.457 |
Ischaemic heart disease | 145 (17.3%) | 46 (21.5%) | 99 (16.53%) | 0.103 |
Liver disease | 24 (2.9%) | 11 (5.14%) | 13 (2.17%) | 0.028 |
Neuromuscular disease | 29 (3.5%) | 11 (5.14%) | 18 (3.01%) | 0.148 |
Recent chemotherapy | 35 (4.2%) | 13 (6.07%) | 22 (3.67%) | 0.137 |
Smoker | 111 (13.2%) | 21 (9.81%) | 90 (15.03%) | 0.057 |
Ex-smoker | 221 (26.3%) | 65 (30.37%) | 156 (26.04%) | 0.222 |
Mean number of co-morbidities, median (range) | 2 (0–6) | 2 (0–6) | 1 (0–6) | 0.009 |